Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
Actual shortage: | 234 (8%) | |
Anticipated shortage: | 20 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NALTREXONE | 50MG | TABLET | Resolved | 2018-11-21 | 2019-02-01 | 67404 |
APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2019-01-30 | 2019-02-01 | 74022 |
APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2019-01-09 | 2019-02-01 | 71676 |
APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2019-01-03 | 2019-02-01 | 71103 |
APO-ACEBUTOLOL | 400MG | TABLET | Resolved | 2018-12-18 | 2019-02-01 | 69911 |
APO-ACEBUTOLOL | 100MG | TABLET | Resolved | 2018-12-12 | 2019-02-01 | 69293 |
APO-ACEBUTOLOL | 100MG | TABLET | Resolved | 2018-12-05 | 2019-02-01 | 68706 |
APO-OXAZEPAM | 30MG | TABLET | Resolved | 2018-12-12 | 2019-01-28 | 69455 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-18 | 2019-01-28 | 69915 |
APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2019-01-03 | 2019-01-28 | 71133 |
TRI-CIRA LO 28 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2018-12-27 | 2019-01-23 | 70526 |
APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-01-03 | 2019-01-23 | 71098 |
APO-ABACAVIR | 300MG | TABLET | Resolved | 2018-11-16 | 2019-01-23 | 67019 |
APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2018-03-20 | 2019-01-18 | 43519 |
APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2018-12-05 | 2019-01-18 | 68709 |
APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2018-11-09 | 2019-01-17 | 66552 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2018-12-12 | 2019-01-17 | 69324 |
APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-11-16 | 2019-01-17 | 67034 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2019-01-03 | 2019-01-17 | 71148 |
APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2018-12-12 | 2019-01-17 | 69302 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OLANZAPINE | 2.5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4738 |
APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
APO-TERAZOSIN | 5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |
APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-FLUVOXAMINE | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
APO-FLUVOXAMINE | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4909 |
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4906 |
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
APO CHLORPROPAMIDE TAB 100MG | 100MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1196 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
APO-PROPRANOLOL | 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1163 |
APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |